Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. (INO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ino · stock forecast · 17 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 17 Wall Street analysts in the past 3 months
Buy
17 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$2.50
Consensus
$2.50
+129.4% upside
Low
$2.50
Median: $2.5 · Last Close: $1.09
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.04 | ↓ 5.00% |
1-day model range: $1.01–$1.06. Peak: $1.06 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · INO · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-01 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-11-14 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-08-14 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-05-14 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-05-14 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-03-19 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-03-19 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-01-13 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-01-10 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2024-11-18 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Inovio Pharmaceuticals, Inc. (INO) stock. Of the recent 66 rating actions, 7 were upgrades and 14 were downgrades. 17 analysts currently cover INO.
Analyst Recommendation Trends
INO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$9M
↓ 93.4% YoY
Revenue Next Year
$62M
↑ 611.3% YoY
EPS This Year
$-0.88
EPS Next Year
$-0.43
↓ 51.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast INO EPS of $-0.88 for the current fiscal year, based on estimates from 3 analysts. The INO revenue forecast is $9M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The INO stock forecast is supported by two independent data sources: analyst consensus ratings from 17 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus INO price target is $2.50 (+129.4% upside), with an analyst consensus of Buy.
The INO short-term stock prediction for tomorrow is $1.04 (-5.00%). The INO stock prediction for 2030 projects a range of $0–$0.
Inovio Pharmaceuticals, Inc. trades on NASDAQ under the ticker INO. The INO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 53% of covering analysts.
Frequently asked questions
INO forecast · 8 questionsAccording to 17 Wall Street analysts, the average 12-month INO price target is $2.50, with a high forecast of $2.50 and a low of $2.50. The median price target is shown in the chart above when available. This implies +129.4% potential upside from the current price of $1.09.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.